SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-008499
Filing Date
2022-05-09
Accepted
2022-05-09 16:14:46
Documents
62
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q alxo-20220331.htm   iXBRL 10-Q 2445393
2 EX-31.1 alxo-ex31_1.htm EX-31.1 20263
3 EX-31.2 alxo-ex31_2.htm EX-31.2 20498
4 EX-32.1 alxo-ex32_1.htm EX-32.1 11212
5 EX-32.2 alxo-ex32_2.htm EX-32.2 11210
  Complete submission text file 0000950170-22-008499.txt   8140114

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT alxo-20220331_cal.xml EX-101.CAL 72155
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alxo-20220331_lab.xml EX-101.LAB 518708
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT alxo-20220331_def.xml EX-101.DEF 184115
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alxo-20220331.xsd EX-101.SCH 61977
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alxo-20220331_pre.xml EX-101.PRE 362213
56 EXTRACTED XBRL INSTANCE DOCUMENT alxo-20220331_htm.xml XML 1310898
Mailing Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-466-7125
ALX ONCOLOGY HOLDINGS INC (Filer) CIK: 0001810182 (see all company filings)

IRS No.: 850642577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39386 | Film No.: 22905115
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences